FOR PREVIEW ONLY (Print)

Shervin Rabizadeh, MD, MBA

Director, Pediatric Inflammatory Bowel Disease Program

Director, Division of Pediatric Gastroenterology

Medical Director, Children's Health Center

Assistant Professor, Pediatrics

8635 W. Third St.
West Medical Office Tower, Suite 1165W
Los Angeles, CA 90077

Phone:

310-423-7100

Fax:

310-423-1402

8723 Alden Drive
Steven Spielberg Building, Suite 240
Los Angeles, CA 90048

Phone:

310-423-7100

Fax:

310-423-1402

Parking Instructions:

Parking is available in the parking lot in front of the Steven Spielberg Building.

Shervin Rabizadeh, MD, MBA

Director, Pediatric Inflammatory Bowel Disease Program

Director, Division of Pediatric Gastroenterology

Medical Director, Children's Health Center

Assistant Professor, Pediatrics

  • Peds - Gastroenterology

Celiac Disease

Crohn's Disease

Gastrointestinal Disorders - Pediatric

Inflammatory Bowel Disease (IBD) - Pediatric

Ulcerative Colitis

Focus on clinical, translational and basic science research to improve the care of children with inflammatory bowel disease (IBD). Study mechanisms of action in the immune dysfunction in IBD, improving and individualizing treatment of children with IBD and investigating novel treatments in pediatric IBD with participation and leadership in clinical trials. Study the relationship of bacteria, immunology, and inflammation as it pertains to diseases such as inflammatory bowel disease and colon cancer.

View NIH Biographical Sketch as a PDF

  • Medical School: Tufts Medical School, 2001
  • Residency: Johns Hopkins University School of Medicine, 2004
  • Fellowship: Johns Hopkins University School of Medicine, 2008
  • CTSI Maternal Child and Adolescent Health Junior Investigator Award, 2011
  • Crohn's and Colitis Foundation of America, 2009
  • American Gastroenterology Association, 2007
  • North American Society of Pediatric Gastroenterology, Hepatology and Nutrition, 2004
  • Wick E*, Rabizadeh S* (*co-first authors), Albesiano E, Wu SW, Rhee KJ, Ortega G, Wu X, Huso DL, Pardoll D, Housseau F, et al. Stat3 Activation in Murine Colitis Induced by Enterotoxigenic Bacteroides fragilis. Inflamm Bowel Dis. 2014;20(5):821-834.
  • Vahabnezhad E, Rabizadeh S, Dubinsky MC. A Ten-Year, Single Tertiary Care Center Experience on the Durability of Infliximab in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. 2014;20(4):606-613.
  • Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 2009;15(9):1016-1022.
  • Rabizadeh S, Rhee KJ, Wu S, Huso D, Gan CM, Golub JE, Wu X, Zhang M, Sears CL. Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm. Bowel Dis. 2007;13(12):1475-1483.
  • Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A. 2011;108(37):15354-15359.
  • Lowe EL, Crother TR, Rabizadeh S, Hu B, Wang H, Chen S, Shimada K, Wong MH, Michelsen KS, Arditi M. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS ONE. 2010;5(9):e13027.
  • Soliman A, Michelsen KS, Karahashi H, Lu J, Meng FJ, Qu X, Crother TR, Rabizadeh S, Chen S, Caplan MS, et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS ONE. 2010;5(10):e15044.

Show moreShow less

English / Persian

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.